COVID-19 rapid evidence summary: Tocilizumab for COVID-19 (update)

This evidence summary has been updated at the request of NHS England, because new evidence was identified: prepublication study results from the nationally prioritised RECOVERY platform study and a published randomised controlled trial (Veiga et al. 2021).

Source:

National Institute for Health and Care Excellence